Hospitals & Clinics
-
Opportunity India Desk Mar 30, 2020 - 3 min readThe 21-day lockdown has dealt a blow to the delivery of essential items even as startups face challenges in production and supply. Although medical devices are part of essential items and were termed as excluded from the lockdown, there continues to be a lot of ambiguity around the matter. Startups manufacturing devices such as ...
-
Opportunity India Desk Sep 20, 2019 - 1 min readIndian pharmacy chain Generico has secured a Series-B round of funding led by venture capital firm Lightbox Ventures. The company runs a network of offline pharmacies selling generic drugs exclusively. The Series-B funding round has also seen participation from its existing investors, Tomorrow Capital and Whiteboard Capital Generico was founded by Siddharth Gadia and Girish Agarwal ...
-
Opportunity India Desk Jul 17, 2019 - 1 min readPristyn Care, India’s leading healthcare startup, has launched its own clinic in Gurugram. The clinic is offering specialty services across General Surgery, Gynaecology, ENT and Urology using advanced laser & laparoscopic techniques. It is designed and established with the aim to provide the best possible care to the patients. Dr. Vaibhav Kapoor, Co-Founder, Pristyn Care, ...
-
Opportunity India Desk Jul 11, 2019 - 2 min readSamsung India Electronics and Apollo Hospitals Group have unveiled ‘Samsung-Apollo Mobile Clinic’ to offer access to quality, preventive healthcare against growing non-communicable diseases (NCDs) to the less privileged. With this launch, both the companies target to leverage technology for ensuring citizens in rural areas in need of healthcare have access to it. Samsung-Apollo Mobile Clinic is well equipped with ...
-
Opportunity India Desk Jul 04, 2019 - 1 min readSaince HealthTech, an Indian arm of Saince Inc, is launching a healthcare platform Qural, a free-to-subscribe, comprehensive healthcare mobile and desktop application for enabling patients, physicians, pharmacies and labs interconnect with each other. The company is planning to launch the app in all the major metros in India. US-based healthcare software solutions company has created ...
-
Opportunity India Desk May 08, 2019 - 1 min readOxxy, a leading healthcare network, is looking to build India's largest hospital chain. It also eyes to expand its presence in key cities. Oxxy has said that 'ByGod Hospitals' has aggregated more than 20 hospitals in the national capital region. It further plans to expand into Mumbai and Bengaluru. Pankaj Gupta, Founder of Oxxy, said, "The vision is to become India's ...
-
Opportunity India Desk Feb 07, 2019 - 1 min readGlenmark Specialty SA, the Swiss subsidiary of Glenmark Pharmaceuticals, has signed an exclusive licensing agreement with Grandpharma (China) Co Ltd for commercialising its novel nasal spray Ryaltris in China. This is Glenmark's third regional licensing deal for Ryaltris. The company has already inked licensing agreements for commercializing Ryaltris in Australia, New Zealand and South Korea. ...
-
Opportunity India Desk Feb 06, 2019 - 1 min readThe Haryana Cabinet, under the chairmanship of Chief Minister Manohar Lal, has approved the Haryana Pharmaceutical Policy 2019 with a view to attract investment in the pharmaceutical sector to the tune of Rs 2,000 crore and generate 25,000 new jobs. The new policy is aiming to develop Haryana into a hub for pharmaceutical manufacturing by ...
-
Opportunity India Desk Dec 14, 2018 - 1 min readCentrient Pharmaceuticals is the new name for DSM Sinochem Pharmaceuticals, the leading manufacturer of beta-lactam antibiotics and a provider of next-generation statins and anti-fungals. The new name has been chosen to reflect the company’s key contribution to modern healthcare, and marks the next phase in its strategic evolution following a change of ownership to Bain ...
-
Opportunity India Desk Dec 10, 2018 - 1 min readDrug firm AstraZeneca Pharma India has inked a distribution agreement with Abbott Healthcare to distribute a diabetes medicine 'Dapagliflozin' in India. Dapagliflozin, an innovative Type 2 diabetes medicine, is a leading diabetes medicine of AstraZeneca Pharma. AstraZeneca Pharma said, "Under the agreement, Abbott will promote and distribute Dapagliflozin under the brand name GLEDEPA. Abbott will also gain the ...